Tirzepatide more effective in blood sugar control and body weight loss than semaglutide
top of page
Browse by category
Search

A new meta-analysis combining 22 studies shows that tirzepatide is superior to semaglutide for both control of blood sugar and in terms...

Journal Watch 27/09/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


Exercise-mimicking drug reduces weight and boosts muscle activity in mice
A new kind of drug, known as ‘exercise mimetics’, has shown promising new in mice that could lead to the development of a new weight-loss...

Sleep apnoea multi-level surgery benefits patients when CPAP is not the answer
Patients with moderate to severe sleep apnoea for people who failed to adapt or are not suited to continuous positive pressure airway...

TREO Foundation reveals 2023 ASMBS Research Grants
The TREO Foundation, formerly the American Society for Metabolic and Bariatric Surgery (ASMBS) Foundation, has awarded two research...


ReShape Lifesciences signs license agreement with Biorad Medisys for Obalon Gastric Balloon
ReShape Lifesciences has signed an exclusive, royalty-bearing license agreement with Biorad Medysis (Biorad) to manufacture,...


22 states in the US have an adult obesity prevalence at or above 35%
New population data from 2022 show 22 states have an adult obesity prevalence at or above 35%, compared to 19 states in 2021, according...


SOS: Lower risk of haematological cancer after bariatric surgery
Bariatric surgery is associated with a reduced incidence of haematological cancer, specifically in women, according to the latest...


New model for in vitro production of human brown fat cells
A team led by investigators at Brigham and Women's Hospital has identified a set of cellular signalling cues that lead up to brown...


ReShape strengthens patent portfolio related to its Obalon Balloon System
ReShape Lifesciences has strengthened the patent portfolio related to its Obalon Balloon System, after to US Patent and Trademark Office...
Browse by tag
bottom of page